Synthesis of N-terminally linked protein and peptide dimers by native chemical ligation

Bioconjugate Chemistry

Volumn 21, Issue 11, 2010, Pages 1943-1947

  Xiao, Junpeng ^a   Hamilton, Brian S ^a   Tolbert, Thomas J ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOACTIVITY; BIOSYNTHESIS; DIMERIZATION; DIMERS; DISEASES; MONOMERS; POLYPEPTIDES;

DIMERIZATIONS; DITHIOESTERS; HALF LIVES; HOMODIMERS; IN-VIVO; N-TERMINALS; NATIVE CHEMICAL LIGATION; PEGYLATION; TARGET RECEPTOR; TERMINAL CYSTEINE;

PEPTIDES;

CYSTEINE; DIMER; HUMAN IMMUNODEFICIENCY VIRUS FUSION INHIBITOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROTEIN CD7H6; PROTEIN G; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGICAL ACTIVITY; DIMERIZATION; DRUG SYNTHESIS; DRUG TARGETING; HUMAN IMMUNODEFICIENCY VIRUS; MOLECULAR WEIGHT; PROTEIN EXPRESSION; VIRUS ENTRY;

EID: 78649234620     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100370j     Document Type: Article

References (40)

1. Klemm, J. D., Schreiber, S. L., and Crabtree, G. R. (1998) Dimerization as a regulatory mechanism in signal transduction Annu. Rev. Immunol. 16, 569-592
2. Mammen, M., Choi, S.-K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. 37, 2754-2794
3. Marianayagam, N. J., Sunde, M., and Matthews, J. M. (2004) The power of two: protein dimerization in biology Trends Biochem. Sci. 29, 618-625
4. Casado, V., Cortes, A., Mallol, J., Perez-Capote, K., Ferre, S., Lluis, C., Franco, R., and Canela, E. I. (2009) GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers? Pharmacol. Ther. 124, 248-257
5. Amoutzias, G. D., Robertson, D. L., Van de Peer, Y., and Oliver, S. G. (2008) Choose your partners: dimerization in eukaryotic transcription factors Trends Biochem. Sci. 33, 220-229
6. Wang, J., Chun, H. J., Wong, W., Spencer, D. M., and Lenardo, M. J. (2001) Caspase-10 is an initiator caspase in death receptor signaling Proc. Natl. Acad. Sci. U.S.A. 98, 13884-13888
7. Renatus, M., Stennicke, H. R., Scott, F. L., Liddington, R. C., and Salvesen, G. S. (2001) Dimer formation drives the activation of the cell death protease caspase 9 Proc. Natl. Acad. Sci. U.S.A. 98, 14250-14255
8. Li, H., Song, H., Heredia, A., Le, N., Redfield, R., Lewis, G. K., and Wang, L. X. (2004) Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein Bioconjugate Chem 15, 783-789
9. Matei, E., Zheng, A., Furey, W., Rose, J., Aiken, C., and Gronenborn, A. M. (2010) Anti-HIV activity of defective cyanovirin-N mutants is restored by dimerization J. Biol. Chem. 285, 13057-13065
10. Hamidi, M., Azadi, A., and Rafiei, P. (2006) Pharmacokinetic consequences of pegylation Drug Delivery 13, 399-409
11. Veronese, F. M. and Mero, A. (2008) The impact of PEGylation on biological therapies BioDrugs 22, 315-329
12. Fishburn, C. S. (2008) The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics J. Pharm. Sci. 97, 4167-4183
13. Pisal, D. S., Kosloski, M. P., and Balu-Iyer, S. V. Delivery of therapeutic proteins J. Pharm. Sci. 99, 2557-2575
14. Cheng, T. L., Wu, P. Y., Wu, M. F., Chern, J. W., and Roffler, S. R. (1999) Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM Bioconjugate Chem. 10, 520-528
15. Sroda, K., Rydlewski, J., Langner, M., Kozubek, A., Grzybek, M., and Sikorski, A. F. (2005) Repeated injections of PEG-PE liposomes generate anti-PEG antibodies Cell Mol. Biol. Lett. 10, 37-47
16. Webster, R., Elliott, V., Park, B. K., Walker, D., Hankin, M., and Taupin, P. (2009) PEG and PEG conjugates toxicity: towards an understanding of the toxicity of PEG and its relevance to PEGylated biologicals, in PEGylated Protein Drugs: Basic Science and Clinical Applications (Veronese, F. M., Ed.) pp 127 - 146, Birkhäuser Basel, Boston, Berlin.
17. Franke, R., Doll, C., and Eichler, J. (2005) Peptide ligation through click chemistry for the generation of assembled and scaffolded peptides Tetrahedron Lett. 46, 4479-4482
18. Canne, L. E., Ferre- D'Amare, A. R., Burley, S. K., and Kent, S. B. H. (1995) Total chemical synthesis of a unique transcription factor-related protein: cMyc-Max J. Am. Chem. Soc. 117, 2998-3007
19. Yang, R., Yang, J., and Weliky, D. P. (2003) Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides Biochemistry 42, 3527-3535
20. Morii, T., Saimei, Y., Okagami, M., Makino, K., and Sugiura, Y. (1997) Factors governing the sequence-selective DNA binding of geometrically constrained peptide dimers J. Am. Chem. Soc. 119, 3649-3655
21. Tam, J. P. and Yu, Q. (2002) A facile ligation approach to prepare three-helix bundles of HIV fusion-state protein mimetics Org. Lett. 4, 4167-4170
22. Rao, C. and Tam, J. P. (1994) Synthesis of peptide dendrimer J. Am. Chem. Soc. 116, 6975-6976
23. Baca, M., Muir, T. W., Schnoelzer, M., and Kent, S. B. H. (1995) Chemical ligation of cysteine-containing peptides: synthesis of a 22 kDa tethered dimer of HIV-1 protease J. Am. Chem. Soc. 117, 1881-1887
24. Torbeev, V. Y. and Kent, S. B. (2007) Convergent chemical synthesis and crystal structure of a 203 amino acid "covalent dimer" HIV-1 protease enzyme molecule Angew. Chem., Int. Ed. 46, 1667-1670
25. Baca, M. and Kent, S. B. H. (2000) Protein backbone engineering through total chemical synthesis: new insight into the mechanism of HIV-1 protease catalysis Tetrahedron 56, 9503-9513
26. Muir, T. W., Sondhi, D., and Cole, P. A. (1998) Expressed protein ligation: a general method for protein engineering Proc. Natl. Acad. Sci. U.S.A. 95, 6705-6710
27. van Baal, I., Malda, H., Synowsky, S. A., van Dongen, J. L., Hackeng, T. M., Merkx, M., and Meijer, E. W. (2005) Multivalent peptide and protein dendrimers using native chemical ligation Angew. Chem., Int. Ed. 44, 5052-5057
28. Ziaco, B., Pensato, S., D'Andrea, L. D., Benedetti, E., and Romanelli, A. (2008) Semisynthesis of dimeric proteins by expressed protein ligation Org. Lett. 10, 1955-1958
29. Stoddart, C. A., Nault, G., Galkina, S. A., Thibaudeau, K., Bakis, P., Bousquet-Gagnon, N., Robitaille, M., Bellomo, M., Paradis, V., Liscourt, P., Lobach, A., Rivard, M. E., Ptak, R. G., Mankowski, M. K., Bridon, D., and Quraishi, O. (2008) Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice J. Biol. Chem. 283, 34045-34052
30. Xiao, J. and Tolbert, T. J. (2009) Synthesis of N-terminally linked protein dimers and trimers by a combined native chemical ligation-CuAAC click chemistry strategy Org. Lett. 11, 4144-4147
31. Dawson, P. E., Muir, T. W., Clark-Lewis, I., and Kent, S. B. (1994) Synthesis of proteins by native chemical ligation Science 266, 776-779
32. Tolbert, T. J. and Wong, C. H. (2002) New methods for proteomic research: preparation of proteins with N-terminal cysteines for labeling and conjugation. Angew. Chem., Int. Ed. 41, 2171 - 2174.
33. Sauer-Eriksson, A. E., Kleywegt, G. J., Uhlen, M., and Jones, T. A. (1995) Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG Structure 3, 265-278
34. Xiao, J. and Tolbert, T. J. (2009) Synthesis of polymerizable protein monomers for protein-acrylamide hydrogel formation Biomacromolecules 10, 1939-1946
35. Root, M. J., Kay, M. S., and Kim, P. S. (2001) Protein design of an HIV-1 entry inhibitor Science 291, 884-888
36. Tolbert, T. J., Franke, D., and Wong, C. H. (2005) A new strategy for glycoprotein synthesis: ligation of synthetic glycopeptides with truncated proteins expressed in E. coli as TEV protease cleavable fusion protein Bioorg. Med. Chem. 13, 909-915
37. Calabrese, L. H. (2002) Anakinra treatment of patients with rheumatoid arthritis Ann. Pharmacother. 36, 1204-1209
38. Hamilton, B. S., Brede, Y., and Tolbert, T. J. (2008) Expression and characterization of human glycosylated interleukin-1 receptor antagonist in Pichia pastoris Protein Expr. Purif. 59, 64-68
39. Wexler-Cohen, Y. and Shai, Y. (2007) Demonstrating the C-terminal boundary of the HIV 1 fusion conformation in a dynamic ongoing fusion process and implication for fusion inhibition FASEB J. 21, 3677-3684
40. Takii, T., Honda, H., Sasayama, S., Kobayashi, T., Ikezawa, H., Udaka, S., Oomoto, Y., and Onozaki, K. (1999) Human interleukin-1 receptor antagonist: large-scale expression in Bacillus brevis 47-5Q J. Interferon Cytokine Res. 19, 1325-1331